{"id":925839,"date":"2026-01-09T09:38:54","date_gmt":"2026-01-09T14:38:54","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/lexicon-pharmaceuticals-publishes-relief-is-possible-ensuring-access-to-effective-treatments-for-chronic-pain\/"},"modified":"2026-01-09T09:38:54","modified_gmt":"2026-01-09T14:38:54","slug":"lexicon-pharmaceuticals-publishes-relief-is-possible-ensuring-access-to-effective-treatments-for-chronic-pain","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/lexicon-pharmaceuticals-publishes-relief-is-possible-ensuring-access-to-effective-treatments-for-chronic-pain\/","title":{"rendered":"Lexicon Pharmaceuticals Publishes \u201cRelief is Possible: Ensuring Access to Effective Treatments for Chronic Pain\u201d\u00a0"},"content":{"rendered":"
\n

\n
\n -White Paper based on October 2025 Roundtable of diverse stakeholders focused on accelerating innovation and expanding access to novel non-opioid therapies-<\/em>
\n <\/strong>\n <\/p>\n

\n
\n -Need for swift action by policymakers to support millions of Americans suffering from chronic pain-<\/em>
\n <\/strong>\n <\/p>\n

THE WOODLANDS, Texas, Jan. 09, 2026 (GLOBE NEWSWIRE) — In October 2025,\u00a0Lexicon Pharmaceuticals, Inc.<\/a> (Nasdaq: LXRX) convened an in-person Roundtable in Washington, D.C., to better understand the unmet needs of people living with chronic pain and identify what more can be done to benefit patients and society at large. The White Paper summarizing the findings, titled \u201cRelief is Possible: Ensuring Access to Effective Treatments for Chronic Pain,\u201d <\/strong>is available as a free download here<\/a>.<\/p>\n

Chronic pain affects one in four American adults and is one of the leading causes of disability, driving direct medical spending, disability claims, and lost productivity each year. Chronic pain costs the United States more than $720 billion annually, including an estimated $190 billion in lost worker productivity1<\/sup>. More than 20 million people suffer from high-impact chronic pain that disrupts daily activities and makes working difficult or impossible. For many years, opioids have been the default treatment option for severe pain, leaving patients and clinicians to navigate the tradeoff between meaningful relief and significant risks of drug diversion, addiction, and overdose.<\/p>\n

The Relief of Chronic Pain Act<\/em>, recently introduced in the U.S. Senate, would ensure Medicare coverage for non-opioid medications specifically indicated for certain chronic pain conditions. It would also reduce or eliminate several barriers that often block timely access to needed care.<\/p>\n

\u201cWe are exploring with partners how to add chronic pain to the legislative agenda, and how to help policymakers and payers prioritize new methods of pain relief,\u201d said Mike Exton, Ph.D., Lexicon\u2019s chief executive officer and director. \u201cWe believe that non-opioid treatments are going to be incredibly important, not only for the patient, but for society at large.\u201d<\/p>\n

Achieving meaningful progress will require a coalition of patients, caregivers, clinicians, patient advocacy groups, professional societies, and others. Swift action to expand access to safe, effective, non-opioid treatments for the more than 60 million Americans living with chronic pain is necessary to achieve progress.<\/p>\n

Chronic pain does not discriminate based on demographics and political viewpoints. It affects rural, suburban, and urban communities alike. It impacts every generation. Addressing it must be a bipartisan, nationwide effort\u2014one that reflects the best of what America can accomplish.<\/p>\n

\n C<\/strong>
\n lick <\/strong>
\n
\n here<\/strong>
\n <\/a>
\n to download \u201cRelief is Possible: Ensuring Access to Effective Treatments for Chronic Pain\u201d<\/strong>\n <\/p>\n

\n About Lexicon Pharmaceuticals<\/strong>
\n
Lexicon is a biopharmaceutical company with a mission of pioneering medicines that transform patients\u2019 lives. Through the Genome5000\u2122 program, Lexicon\u2019s unique genomics target discovery platform, Lexicon scientists studied the role and function of nearly 5,000 genes and identified more than 100 protein targets with significant therapeutic potential in a range of diseases. Through the precise targeting of these proteins, Lexicon is pioneering the discovery and development of innovative medicines to safely and effectively treat disease. Lexicon has advanced multiple medicines to market and has a pipeline of promising drug candidates in discovery and clinical and preclinical development in heart failure, neuropathic pain, obesity, cardiology, diabetes and other indications.\u00a0For additional information, please visit www.lexpharma.com<\/a>.<\/p>\n

\n References<\/strong>
\n
\n 1<\/sup>Guy GP Jr, et al. Economic costs of chronic pain\u2014United States, 2021. Med Care. 2025 Sep. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/40730349\/<\/p>\n

For Investor and Media Inquiries<\/strong>
Lisa DeFrancesco
Lexicon Pharmaceuticals, Inc.
lexinvest@lexpharma.com<\/a><\/p>\n

\"\"
\n
\n \"\"\n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

-White Paper based on October 2025 Roundtable of diverse stakeholders focused on accelerating innovation and expanding access to novel non-opioid therapies- -Need for swift action by policymakers to support millions of Americans suffering from chronic pain- THE WOODLANDS, Texas, Jan. 09, 2026 (GLOBE NEWSWIRE) — In October 2025,\u00a0Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) convened an in-person Roundtable in Washington, D.C., to better understand the unmet needs of people living with chronic pain and identify what more can be done to benefit patients and society at large. The White Paper summarizing the findings, titled \u201cRelief is Possible: Ensuring Access to Effective Treatments for Chronic Pain,\u201d is available as a free download here. Chronic pain affects one in four American adults and is … <\/p>\n

Continue reading “Lexicon Pharmaceuticals Publishes \u201cRelief is Possible: Ensuring Access to Effective Treatments for Chronic Pain\u201d\u00a0“<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-925839","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nLexicon Pharmaceuticals Publishes \u201cRelief is Possible: Ensuring Access to Effective Treatments for Chronic Pain\u201d\u00a0 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/lexicon-pharmaceuticals-publishes-relief-is-possible-ensuring-access-to-effective-treatments-for-chronic-pain\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Lexicon Pharmaceuticals Publishes \u201cRelief is Possible: Ensuring Access to Effective Treatments for Chronic Pain\u201d\u00a0 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"-White Paper based on October 2025 Roundtable of diverse stakeholders focused on accelerating innovation and expanding access to novel non-opioid therapies- -Need for swift action by policymakers to support millions of Americans suffering from chronic pain- THE WOODLANDS, Texas, Jan. 09, 2026 (GLOBE NEWSWIRE) — In October 2025,\u00a0Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) convened an in-person Roundtable in Washington, D.C., to better understand the unmet needs of people living with chronic pain and identify what more can be done to benefit patients and society at large. The White Paper summarizing the findings, titled \u201cRelief is Possible: Ensuring Access to Effective Treatments for Chronic Pain,\u201d is available as a free download here. Chronic pain affects one in four American adults and is … Continue reading "Lexicon Pharmaceuticals Publishes \u201cRelief is Possible: Ensuring Access to Effective Treatments for Chronic Pain\u201d\u00a0"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/lexicon-pharmaceuticals-publishes-relief-is-possible-ensuring-access-to-effective-treatments-for-chronic-pain\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-01-09T14:38:54+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTYyMjc1OCM3MzUyNzU4IzIwMDM5Njc=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lexicon-pharmaceuticals-publishes-relief-is-possible-ensuring-access-to-effective-treatments-for-chronic-pain\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lexicon-pharmaceuticals-publishes-relief-is-possible-ensuring-access-to-effective-treatments-for-chronic-pain\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Lexicon Pharmaceuticals Publishes \u201cRelief is Possible: Ensuring Access to Effective Treatments for Chronic Pain\u201d\u00a0\",\"datePublished\":\"2026-01-09T14:38:54+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lexicon-pharmaceuticals-publishes-relief-is-possible-ensuring-access-to-effective-treatments-for-chronic-pain\\\/\"},\"wordCount\":577,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lexicon-pharmaceuticals-publishes-relief-is-possible-ensuring-access-to-effective-treatments-for-chronic-pain\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTYyMjc1OCM3MzUyNzU4IzIwMDM5Njc=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lexicon-pharmaceuticals-publishes-relief-is-possible-ensuring-access-to-effective-treatments-for-chronic-pain\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lexicon-pharmaceuticals-publishes-relief-is-possible-ensuring-access-to-effective-treatments-for-chronic-pain\\\/\",\"name\":\"Lexicon Pharmaceuticals Publishes \u201cRelief is Possible: Ensuring Access to Effective Treatments for Chronic Pain\u201d\u00a0 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lexicon-pharmaceuticals-publishes-relief-is-possible-ensuring-access-to-effective-treatments-for-chronic-pain\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lexicon-pharmaceuticals-publishes-relief-is-possible-ensuring-access-to-effective-treatments-for-chronic-pain\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTYyMjc1OCM3MzUyNzU4IzIwMDM5Njc=\",\"datePublished\":\"2026-01-09T14:38:54+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lexicon-pharmaceuticals-publishes-relief-is-possible-ensuring-access-to-effective-treatments-for-chronic-pain\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lexicon-pharmaceuticals-publishes-relief-is-possible-ensuring-access-to-effective-treatments-for-chronic-pain\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lexicon-pharmaceuticals-publishes-relief-is-possible-ensuring-access-to-effective-treatments-for-chronic-pain\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTYyMjc1OCM3MzUyNzU4IzIwMDM5Njc=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTYyMjc1OCM3MzUyNzU4IzIwMDM5Njc=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lexicon-pharmaceuticals-publishes-relief-is-possible-ensuring-access-to-effective-treatments-for-chronic-pain\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Lexicon Pharmaceuticals Publishes \u201cRelief is Possible: Ensuring Access to Effective Treatments for Chronic Pain\u201d\u00a0\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Lexicon Pharmaceuticals Publishes \u201cRelief is Possible: Ensuring Access to Effective Treatments for Chronic Pain\u201d\u00a0 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/lexicon-pharmaceuticals-publishes-relief-is-possible-ensuring-access-to-effective-treatments-for-chronic-pain\/","og_locale":"en_US","og_type":"article","og_title":"Lexicon Pharmaceuticals Publishes \u201cRelief is Possible: Ensuring Access to Effective Treatments for Chronic Pain\u201d\u00a0 - Market Newsdesk","og_description":"-White Paper based on October 2025 Roundtable of diverse stakeholders focused on accelerating innovation and expanding access to novel non-opioid therapies- -Need for swift action by policymakers to support millions of Americans suffering from chronic pain- THE WOODLANDS, Texas, Jan. 09, 2026 (GLOBE NEWSWIRE) — In October 2025,\u00a0Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) convened an in-person Roundtable in Washington, D.C., to better understand the unmet needs of people living with chronic pain and identify what more can be done to benefit patients and society at large. The White Paper summarizing the findings, titled \u201cRelief is Possible: Ensuring Access to Effective Treatments for Chronic Pain,\u201d is available as a free download here. Chronic pain affects one in four American adults and is … Continue reading \"Lexicon Pharmaceuticals Publishes \u201cRelief is Possible: Ensuring Access to Effective Treatments for Chronic Pain\u201d\u00a0\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/lexicon-pharmaceuticals-publishes-relief-is-possible-ensuring-access-to-effective-treatments-for-chronic-pain\/","og_site_name":"Market Newsdesk","article_published_time":"2026-01-09T14:38:54+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTYyMjc1OCM3MzUyNzU4IzIwMDM5Njc=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lexicon-pharmaceuticals-publishes-relief-is-possible-ensuring-access-to-effective-treatments-for-chronic-pain\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lexicon-pharmaceuticals-publishes-relief-is-possible-ensuring-access-to-effective-treatments-for-chronic-pain\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Lexicon Pharmaceuticals Publishes \u201cRelief is Possible: Ensuring Access to Effective Treatments for Chronic Pain\u201d\u00a0","datePublished":"2026-01-09T14:38:54+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lexicon-pharmaceuticals-publishes-relief-is-possible-ensuring-access-to-effective-treatments-for-chronic-pain\/"},"wordCount":577,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lexicon-pharmaceuticals-publishes-relief-is-possible-ensuring-access-to-effective-treatments-for-chronic-pain\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTYyMjc1OCM3MzUyNzU4IzIwMDM5Njc=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lexicon-pharmaceuticals-publishes-relief-is-possible-ensuring-access-to-effective-treatments-for-chronic-pain\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/lexicon-pharmaceuticals-publishes-relief-is-possible-ensuring-access-to-effective-treatments-for-chronic-pain\/","name":"Lexicon Pharmaceuticals Publishes \u201cRelief is Possible: Ensuring Access to Effective Treatments for Chronic Pain\u201d\u00a0 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lexicon-pharmaceuticals-publishes-relief-is-possible-ensuring-access-to-effective-treatments-for-chronic-pain\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lexicon-pharmaceuticals-publishes-relief-is-possible-ensuring-access-to-effective-treatments-for-chronic-pain\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTYyMjc1OCM3MzUyNzU4IzIwMDM5Njc=","datePublished":"2026-01-09T14:38:54+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lexicon-pharmaceuticals-publishes-relief-is-possible-ensuring-access-to-effective-treatments-for-chronic-pain\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/lexicon-pharmaceuticals-publishes-relief-is-possible-ensuring-access-to-effective-treatments-for-chronic-pain\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lexicon-pharmaceuticals-publishes-relief-is-possible-ensuring-access-to-effective-treatments-for-chronic-pain\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTYyMjc1OCM3MzUyNzU4IzIwMDM5Njc=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTYyMjc1OCM3MzUyNzU4IzIwMDM5Njc="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lexicon-pharmaceuticals-publishes-relief-is-possible-ensuring-access-to-effective-treatments-for-chronic-pain\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Lexicon Pharmaceuticals Publishes \u201cRelief is Possible: Ensuring Access to Effective Treatments for Chronic Pain\u201d\u00a0"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/925839","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=925839"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/925839\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=925839"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=925839"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=925839"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}